On Mar. 4, 2021, China released the finalized Provisions for Management of New Cosmetic Ingredient Registration and Notification Dossiers, which will come into effect on May 1. The Provisions detail the documentation requirements for new cosmetic ingredients (NCI) registration and notification.

China eases the market entry requirements for NCI by adopting classified management. Only high-risk NCI require registration with NMPA, while low-risk NCI requires only a simple notification that is deemed to be completed just after submitting notification documents. NCI enterprises will usher in a golden period of expedited market access to China.

Although the entry threshold for NCI has been lowered, the documentation requirements are still very complicated. During the webinar, Joanna Ru from REACH24H will interpret the NCI registration and notification procedures and documentation requirements, and give insightful regulatory compliance recommendations to enterprises.

*Click here to visit another webinar interpreting cosmetic products registration and notification documentation requirements.

1. Background

1.1 What is new cosmetic ingredient (NCI)?

1.2 Who need to conduct new cosmetic ingredient application?

1.3 Related regulations & Competent authority

1.4 What is the difference between NCI application & Ingredient Submission Code

2. Classified Management & NCI Application Procedures

2.1 Classified management

2.2 NCI application procedures

3. Dossier Requirements

3.1 NMPA user account application

3.2 R&D report

3.3 QC and manufacturing process

3.4 Toxicological testing requirements & conditional acceptance of alternative methods

4. Obligations During the Monitoring Period & Suggestions

*The final outline may be subject to subtle revision.